Italy
· Delayed Price · Currency is EUR Svas Biosana Statistics
Total Valuation
Svas Biosana has a market cap or net worth of EUR 42.21 million. The enterprise value is 70.79 million.
| Market Cap | 42.21M |
| Enterprise Value | 70.79M |
Important Dates
The last earnings date was Monday, April 14, 2025.
| Earnings Date | Apr 14, 2025 |
| Ex-Dividend Date | Jun 9, 2025 |
Share Statistics
Svas Biosana has 5.40 million shares outstanding.
| Current Share Class | 5.40M |
| Shares Outstanding | 5.40M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 6.35% |
| Owned by Institutions (%) | 9.98% |
| Float | 1.95M |
Valuation Ratios
The trailing PE ratio is 7.18 and the forward PE ratio is 6.02.
| PE Ratio | 7.18 |
| Forward PE | 6.02 |
| PS Ratio | 0.35 |
| PB Ratio | 0.67 |
| P/TBV Ratio | 0.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 12.05 |
| EV / Sales | 0.59 |
| EV / EBITDA | 4.92 |
| EV / EBIT | 7.22 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.03, with a Debt / Equity ratio of 1.05.
| Current Ratio | 2.03 |
| Quick Ratio | 1.49 |
| Debt / Equity | 1.05 |
| Debt / EBITDA | 4.59 |
| Debt / FCF | n/a |
| Interest Coverage | 5.46 |
Financial Efficiency
Return on equity (ROE) is 9.65% and return on invested capital (ROIC) is 4.81%.
| Return on Equity (ROE) | 9.65% |
| Return on Assets (ROA) | 3.70% |
| Return on Invested Capital (ROIC) | 4.81% |
| Return on Capital Employed (ROCE) | 9.49% |
| Revenue Per Employee | 367,935 |
| Profits Per Employee | 17,972 |
| Employee Count | 323 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 3.21 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.14% in the last 52 weeks. The beta is 0.91, so Svas Biosana's price volatility has been similar to the market average.
| Beta (5Y) | 0.91 |
| 52-Week Price Change | -9.14% |
| 50-Day Moving Average | 7.30 |
| 200-Day Moving Average | 7.47 |
| Relative Strength Index (RSI) | 50.13 |
| Average Volume (20 Days) | 3,304 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Svas Biosana had revenue of EUR 120.31 million and earned 5.88 million in profits.
| Revenue | 120.31M |
| Gross Profit | 13.29M |
| Operating Income | 9.80M |
| Pretax Income | 8.01M |
| Net Income | 5.88M |
| EBITDA | 14.38M |
| EBIT | 9.80M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 37.39 million in cash and 65.97 million in debt, giving a net cash position of -28.58 million or -5.29 per share.
| Cash & Cash Equivalents | 37.39M |
| Total Debt | 65.97M |
| Net Cash | -28.58M |
| Net Cash Per Share | -5.29 |
| Equity (Book Value) | 62.84M |
| Book Value Per Share | n/a |
| Working Capital | 64.17M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 11.04%, with operating and profit margins of 8.15% and 4.88%.
| Gross Margin | 11.04% |
| Operating Margin | 8.15% |
| Pretax Margin | 6.66% |
| Profit Margin | 4.88% |
| EBITDA Margin | 11.96% |
| EBIT Margin | 8.15% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 3.20%.
| Dividend Per Share | 0.25 |
| Dividend Yield | 3.20% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 3.20% |
| Earnings Yield | 13.92% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |